Inflammation and Cardiovascular Disease: The Future

Despite considerable advances in reducing the global burden of atherosclerotic cardiovascular disease by targeting conventional risk factors, significant residual risk remains, with low-grade inflammation being one of the strongest risk modifiers. Inflammatory processes within the arterial wall or s...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Natalie, Lechner, Katharina, Waldeyer, Christoph, Shapiro, Michael D, Koenig, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2021
Materias:
Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157394/
https://www.ncbi.nlm.nih.gov/pubmed/34093741
http://dx.doi.org/10.15420/ecr.2020.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157394/
https://www.ncbi.nlm.nih.gov/pubmed/34093741
http://dx.doi.org/10.15420/ecr.2020.50

Ejemplares similares